When IL-17A binds to its IL17R receptor, an Act1-FADD signaling cascade induces retinal endothelial cell death, vascular impairment, and the onset of non-proliferative diabetic retinopathy in diabetic mice [25,26]. Here, TRAF3IP2 is linked to proliferative diabetic retinopathy.